Agomelatine is a melatonergic antidepressant developed by the pharmaceutical company Servier. It is marketed for the treatment of major depressive disorder and has been reported to not produce discontinuation syndrome and have no sexual side effects compared to SSRIs, SNRIs and the older tricyclic antidepressants. Agomelatine may also have positive effects on sleep.

1. Agomelatine - Mental Illness Another "blockbuster" class of drugs.
 
2. Agomelatine has antidepressant, anti-anxiety, adjusting sleep rhythm and regulating the role of the biological clock, and its adverse reactions, sexual performance without adverse effects, and no withdrawal response.
 
3. Agomelatine has a good effect on patients with depression, and adverse reactions are very small.